DOSSIER · 13F Holders · Q4 2025Healthcare · Pharmaceutical Preparations
MLTX
MOONLAKE IMMUNOTHERAPEUTICS
161 institutions still hold MOONLAKE IMMUNOTHERAPEUTICS as of Q4 2025. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 61559X104·Pharmaceutical Preparations·161 13F holders·last filed Dec 31, 2025
AI Holders Summary · Q4 2025
161 institutions reported MLTX in Q4 2025. BVF INC/IL leads at 28.8% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 9
141 more holders available. Log in →